search results for

refine results

sort by

Date
Relevance

result type

Articles
Video

Wires
Press Releases

Juno Therapeutics CEO gives 2017 outlook after drug trial halt cut stock in half last year

Hans Bishop gives an update on Juno Therapeutics in an exclusive interview with CNBC's Meg Tirrell.

Source: CNBC.com

CNBC PRO: Juno Therapeutics CEO Hans Bishop

The full interview with Juno Therapeutics CEO Hans Bishop.

Source: CNBC.com

Markets feel a lot like 1980: Pro

Peter Boockvar, The Lindsey Group, and Hans Olsen, Stifel Wealth & Investment Management, talk about regulations and market valuations. The market is pricing to perfection and Trump hasn't come up against K Street yet, says Olsen.

Source: CNBC.com